Denali Therapeutics (DNLI) Income Statement (2017 - 2026)
Income Statement report data from Mar 31, 2017 to Mar 31, 2026 for Denali Therapeutics (DNLI).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | - | 1.27M (-99.57%) | 294M (+736.99%) | 35M (+242.50%) | 10M (+5600.00%) | 180K (-99.66%) | 52M (+24.54%) | 42M (+236.85%) | 13M (+136.48%) | 5.29M (-76.94%) | 23M (+189.65%) | 7.92M (-97.50%) | 317M (+3273.91%) | 9.39M (+61.62%) | 5.81M (+63.66%) | 3.55M (-22.83%) | 4.60M (-65.95%) | 14M (+229.51%) | 4.10M (-0.24%) | 4.11M (-96.73%) | 126M (+10368.33%) | 1.20M (-27.27%) | 1.65M (+157.81%) | 640K | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||||||||||
Research And Development | 104M (+6.07%) | 98M (-3.96%) | 102M (-0.73%) | 103M (-11.64%) | 116M (+16.47%) | 100M (+1.58%) | 98M (+7.48%) | 91M (-14.60%) | 107M (-0.72%) | 108M (+20.12%) | 90M (-7.98%) | 98M (-24.30%) | 129M (+39.85%) | 92M (+4.92%) | 88M (-5.34%) | 93M (+7.71%) | 86M (+26.84%) | 68M (-5.14%) | 72M (+8.90%) | 66M (+9.13%) | 60M (+9.99%) | 55M (+1.94%) | 54M (+1.03%) | 53M (+4.17%) | 51M (-1.03%) | 52M (-1.88%) | 53M (+1.27%) | 52M (+38.72%) | 37M (-6.29%) | 40M (+31.63%) | 30M (-41.84%) | 52M (+150.38%) | 21M (+12.72%) | 18M (-0.27%) | 19M (-2.53%) | 19M (+2.87%) | 18M |
Selling General And Administrative | 34M (-15.08%) | 39M (+11.22%) | 35M (+9.95%) | 32M (+9.95%) | 29M (-2.36%) | 30M (+20.48%) | 25M (-0.95%) | 25M (-0.20%) | 25M (+1.90%) | 25M (-2.21%) | 25M (-3.02%) | 26M (-3.76%) | 27M (+15.39%) | 24M (+1.12%) | 23M (+9.92%) | 21M (-6.12%) | 23M (+3.58%) | 22M (+12.63%) | 19M (+1.42%) | 19M (+0.58%) | 19M (+5.28%) | 18M (+13.79%) | 16M (+13.17%) | 14M (+11.23%) | 13M (+15.44%) | 11M (-3.03%) | 11M (-25.60%) | 15M (+61.98%) | 9.31M (-15.75%) | 11M (+25.00%) | 8.84M (+28.12%) | 6.90M (+23.88%) | 5.57M (+9.86%) | 5.07M (+34.48%) | 3.77M (+5.90%) | 3.56M (+8.87%) | 3.27M |
Operating Expenses | 137M (-0.01%) | 137M (-0.04%) | 137M (+1.83%) | 135M (-7.29%) | 146M (+12.11%) | 130M (+5.41%) | 123M (+5.66%) | 117M (-11.84%) | 132M (-0.24%) | 133M (+15.22%) | 115M (-6.94%) | 124M (-20.72%) | 156M (+34.88%) | 116M (+4.12%) | 111M (-2.50%) | 114M (+4.84%) | 109M (+21.20%) | 90M (-1.36%) | 91M (+7.22%) | 85M (+7.10%) | 79M (+8.80%) | 73M (+4.65%) | 70M (+3.56%) | 67M (+5.58%) | 64M (+1.83%) | 62M (-2.09%) | 64M (-4.78%) | 67M (+43.35%) | 47M (-8.32%) | 51M (+30.11%) | 39M (-33.66%) | 59M (+123.68%) | 26M (+12.11%) | 24M (+5.61%) | 22M (-1.24%) | 23M (+3.82%) | 22M |
Depreciation And Amortization | 2.85M (-67.83%) | 8.86M | - | - | 2.33M (-58.61%) | 5.63M | - | - | 2.16M (-67.66%) | 6.68M | - | - | 10M (+21.08%) | 8.30M | - | - | 2.08M (-67.95%) | 6.49M | - | - | 2.11M (-67.13%) | 6.42M | - | - | 2.11M (-62.25%) | 5.59M | - | - | 2.40M (-63.41%) | 6.56M | - | - | 850K (-63.83%) | 2.35M | - | - | 730K |
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Income | -137.36M (0.00%) | -137.36M (-0.05%) | -137.43M (+1.83%) | -134.96M (-7.29%) | -145.58M (+12.11%) | -129.85M (+5.41%) | -123.19M (+5.66%) | -116.59M (-0.95%) | -117.71M (-11.21%) | -132.57M (+16.50%) | -113.79M | 170M | -120.81M (+14.69%) | -105.34M (-2.00%) | -107.49M (+75.01%) | -61.42M (-7.64%) | -66.50M (-13.77%) | -77.12M (-9.90%) | -85.59M (+38.45%) | -61.82M (-13.20%) | -71.22M | 244M | -60.12M (-1.89%) | -61.28M (+2.18%) | -59.97M (+3.83%) | -57.76M (+15.17%) | -50.15M (-20.09%) | -62.76M (+47.64%) | -42.51M | 75M | -37.96M (-33.84%) | -57.38M (+122.83%) | -25.75M (+9.39%) | -23.54M (+5.61%) | -22.29M (-1.24%) | -22.57M (+3.82%) | -21.74M |
Ebit | -137.36M (0.00%) | -137.36M (-0.05%) | -137.43M (+1.83%) | -134.96M (-7.29%) | -145.58M (+12.11%) | -129.85M (+5.41%) | -123.19M (+5.66%) | -116.59M (-0.95%) | -117.71M (-11.21%) | -132.57M (+16.50%) | -113.79M | 170M | -120.81M (+14.69%) | -105.34M (-2.00%) | -107.49M (+75.01%) | -61.42M (-7.64%) | -66.50M (-13.77%) | -77.12M (-9.90%) | -85.59M (+38.45%) | -61.82M (-13.20%) | -71.22M | 244M | -60.12M (-1.89%) | -61.28M (+2.18%) | -59.97M (+3.83%) | -57.76M (+15.17%) | -50.15M (-20.09%) | -62.76M (+47.64%) | -42.51M | 75M | -37.96M (-33.84%) | -57.38M (+122.83%) | -25.75M (+9.39%) | -23.54M (+5.61%) | -22.29M (-1.24%) | -22.57M (+3.82%) | -21.74M |
EBITDA | -134.51M (-10.25%) | -149.88M (+18.11%) | -126.90M (+2.24%) | -124.12M (-13.35%) | -143.25M (-9.20%) | -157.77M (+47.19%) | -107.19M (+8.24%) | -99.03M (-14.30%) | -115.55M (-24.60%) | -153.24M (+54.24%) | -99.35M | 183M | -110.77M (+6.63%) | -103.88M (+0.56%) | -103.30M (+75.77%) | -58.77M (-8.77%) | -64.42M (-11.47%) | -72.77M (-13.97%) | -84.59M (+39.38%) | -60.69M (-12.18%) | -69.11M | 246M | -58.17M (-0.87%) | -58.68M (+1.42%) | -57.86M (-3.66%) | -60.06M (+29.52%) | -46.37M (-20.94%) | -58.65M (+46.26%) | -40.10M | 76M | -35.37M (-35.36%) | -54.72M (+119.85%) | -24.89M (+12.78%) | -22.07M (+1.05%) | -21.84M (-1.31%) | -22.13M (+5.33%) | -21.01M |
Other Income / Expenses | |||||||||||||||||||||||||||||||||||||
Other Non Operating Income | - | - | - | - | - | - | - | - | - | 52M (+256.72%) | 14M (+11.94%) | 13M (+16.95%) | 11M (-25.32%) | 15M (+252.51%) | 4.19M (+58.11%) | 2.65M (+107.03%) | 1.28M (-72.17%) | 4.60M (+360.00%) | 1.00M (-11.50%) | 1.13M (-4.24%) | 1.18M (-87.23%) | 9.24M (+376.29%) | 1.94M (-25.38%) | 2.60M (-15.31%) | 3.07M (-79.83%) | 15M (+302.65%) | 3.78M (-8.03%) | 4.11M (+16.76%) | 3.52M (-65.25%) | 10M (+291.12%) | 2.59M (-2.63%) | 2.66M (+28.50%) | 2.07M (+5.61%) | 1.96M (+345.45%) | 440K (+2.33%) | 430K (+2.38%) | 420K |
Net Income | |||||||||||||||||||||||||||||||||||||
Income Tax Expense | - | 100K | - | - | - | 70K | - | - | - | 30K | - | - | - | -10.00K | - | 30K | - | -570.00K | - | - | - | 820K (+1266.67%) | 60K (-25.00%) | 80K | -130.00K | 80K | -110.00K (-64.52%) | -310.00K | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -128.45M (-0.08%) | -128.55M (+1.30%) | -126.90M (+2.24%) | -124.12M (-6.66%) | -132.97M (+15.88%) | -114.75M (+7.05%) | -107.19M (+8.24%) | -99.03M (-2.72%) | -101.80M (-14.79%) | -119.47M (+20.25%) | -99.35M | 183M | -109.78M (+11.25%) | -98.68M (-4.47%) | -103.30M (+75.71%) | -58.79M (-9.86%) | -65.22M (-13.34%) | -75.26M (-11.03%) | -84.59M (+39.38%) | -60.69M (-13.35%) | -70.04M | 245M | -58.23M (-0.90%) | -58.76M (+3.52%) | -56.76M (+5.07%) | -54.02M (+16.77%) | -46.26M (-20.71%) | -58.34M (+49.63%) | -38.99M | 78M | -35.37M (-35.36%) | -54.72M (+131.08%) | -23.68M (+3.45%) | -22.89M (+4.81%) | -21.84M (-1.31%) | -22.13M (+3.80%) | -21.32M |
Net Income | -128.45M (-0.08%) | -128.55M (+1.30%) | -126.90M (+2.24%) | -124.12M (-6.66%) | -132.97M (+15.88%) | -114.75M (+7.05%) | -107.19M (+8.24%) | -99.03M (-2.72%) | -101.80M (-14.79%) | -119.47M (+20.25%) | -99.35M | 183M | -109.78M (+11.25%) | -98.68M (-4.47%) | -103.30M (+75.71%) | -58.79M (-9.86%) | -65.22M (-13.34%) | -75.26M (-11.03%) | -84.59M (+39.38%) | -60.69M (-13.35%) | -70.04M | 245M | -58.23M (-0.90%) | -58.76M (+3.52%) | -56.76M (+5.07%) | -54.02M (+16.77%) | -46.26M (-20.71%) | -58.34M (+49.63%) | -38.99M | 78M | -35.37M (-35.36%) | -54.72M (+131.08%) | -23.68M (+3.45%) | -22.89M (+4.81%) | -21.84M (-1.31%) | -22.13M (+3.80%) | -21.32M |
Comprehensive Income Net Of Tax | -129.81M (-74.74%) | -513.88M (+305.46%) | -126.74M (+1.21%) | -125.22M (-5.81%) | -132.95M (-68.45%) | -421.40M (+325.66%) | -99.00M (-1.38%) | -100.39M (-3.23%) | -103.74M (-24.66%) | -137.69M (+39.70%) | -98.56M | 184M | -105.41M (-68.09%) | -330.38M (+221.13%) | -102.88M (+66.42%) | -61.82M (-14.10%) | -71.97M (-75.42%) | -292.83M (+245.56%) | -84.74M (+39.31%) | -60.83M (-13.14%) | -70.03M | 71M | -58.77M (-0.46%) | -59.04M (+4.90%) | -56.28M (-71.37%) | -196.61M (+322.09%) | -46.58M (-19.40%) | -57.79M (+52.04%) | -38.01M (+4.08%) | -36.52M (+3.49%) | -35.29M (-35.75%) | -54.93M (+123.29%) | -24.60M (-72.10%) | -88.18M (+306.36%) | -21.70M (-1.90%) | -22.12M (+3.66%) | -21.34M |